{'fraction_non_alphanumeric': 0.011682242990654205, 'fraction_numerical': 0.0, 'mean_word_length': 5.5, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Challenges in the Design of Phase I and Early Phase II Studies

Successful completion of a clinical trial is dependent among many factors which include the appropriate selection of a study population and dose, study design, and individual subject's perceptions about participation. Salient points in the design and conduct of early clinical trials for the development of hypothetical oral cephalosporin antibiotic are discussed.